An Immunogenicity and Safety Study of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in 2-month-old Infants

NCT03526978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Investigational sIPV
BIOLOGICAL: Control IPV

Sponsor

Sinovac Biotech Co., Ltd